Investment Firm
Overview
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
Apr 08, 2014
Series A
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
2
Investor Name |
---|
F-Prime Capital |
New Enterprise Associates |
Mersana Therapeutics raised $14505371 on 2014-04-08 in Series A
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
Company Funding History
12
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Apr 08, 2014 | Series A - Mersana Therapeutics | 2 | - | 14.5M |
Apr 18, 2012 | Debt Financing - Mersana Therapeutics | - | 10.0M | |
Jul 31, 2012 | Series A - Mersana Therapeutics | 6 | - | 27.0M |
Nov 08, 2005 | Venture Round - Mersana Therapeutics | 8 | - | 21.0M |
Recent Activity
There is no recent news or activity for this profile.